Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Investigative Site, Mendoza

Investigative Site, Baltimore

Investigative Site, Richmond

Investigative Site, Gainesville

Investigative Site, Orlando

Investigative Site, Port Charlotte

Investigative Site, Birmingham

Investigative Site, Huntsville

Investigative Site, Tupelo

Investigative Site, Cincinnati

Investigative Site, Indianapolis

Investigative Site, Lansing

Investigative Site, Petoskey

Investigative Site, Saint Paul

Investigative Site, Shreveport

Investigative Site, Houston

Investigative Site, Amarillo

Investigative Site, Tacoma

Investigative Site, Marshfield

Investigative Site, Holmdel

Investigative Site, Buenos Aires

Investigative Site, Buenos Aires

Investigative Site, Buenos Aires

Investigative Site, Buenos Aires

Investigative Site, Calgary

Investigative Site, Edmonton

Investigative Site, Halifax

Investigative Site, Ottawa

Investigative Site, Ottawa

Investigative Site, Toronto

Investigative Site, Montreal

Investigative Site, Montreal

Investigative Site, Montreal

Investigative Site, Terrebonne

Investigative Site, Santiago

Investigative Site, Aalborg

Investigative Site, Arhus C

Investigative Site, Esbjerg

Investigative Site, Fredericia

Investigative Site, Frederikssund

Investigative Site, Herlev

Investigative Site, Hjørring

Investigative Site, Holstebro

Investigative Site, Horsens

Investigative Site, Hvidovre

Investigative Site, København NV

Investigative Site, København S

Investigative Site, Køge

Investigative Site, Magdalena de las Salinas

Investigative Site, Malmo

Investigative Site, Mölndal

Investigative Site, Örebro

Investigative Site, Stockholm

Investigative Site, Uppsala